B cells are required for tumor-targeting Salmonella in host

Applied Microbiology and Biotechnology

Volumn 92, Issue 6, 2011, Pages 1251-1260

  Lee, Che Hsin ^a   Hsieh, Jeng Long ^b   Wu, Chao Liang ^c   Hsu, Hui Chun ^d   Shiau, Ai Li ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

B cell; Natural antibody; Salmonella; Tumor targeting

Indexed keywords

ADAPTIVE IMMUNE RESPONSE; ANTI-TUMOR ACTIVITIES; B CELLS; BACTERIAL LOAD; BODY WEIGHT; CYTOKINES; HOST IMMUNE RESPONSE; IMMUNORESPONSE; SYSTEMIC ADMINISTRATION; TUMOR GROWTH; TUMOR REGRESSION; TUMOR SITE; TUMOR TARGETING; WILD TYPES;

ANTIBODIES; BACTERIOLOGY; CELLS; CYTOLOGY; IMMUNOLOGY; MAMMALS; TUMORS;

SALMONELLA;

ANTINEOPLASTIC AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; ONCOLYTIC SALMONELLA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTATION; ANTIBODY; BACTERIUM; BIOACCUMULATION; BIOENGINEERING; BODY MASS; HOST-PATHOGEN INTERACTION; IMMUNE RESPONSE; INHIBITION; PROTEIN; RODENT; TUMOR; WEIGHT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BACTEREMIA; BACTERIAL LOAD; BODY WEIGHT; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; HUMORAL IMMUNE DEFICIENCY; INFLAMMATION; LEWIS CARCINOMA; LYMPHOCYTE DEPLETION; MALE; MOUSE; NONHUMAN; SALMONELLA CHOLERAESUIS; TISSUE DISTRIBUTION; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BIOLOGICAL THERAPY; CELL LINE, TUMOR; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA;

EID: 82455208995     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3386-0     Document Type: Article

References (25)

1. TA Barr S Brown P Mastroeni D Gray 2009 B cell intrinsic MyD88 signals drive IFN-γ production from T cells and control switching to IgG2c J Immunol 183 1005 1012 10.4049/jimmunol.0803706 1:CAS:528:DC%2BD1MXotFWhu7k%3D
2. C Calcaterra L Sfondrini A Rossini M Sommariva C Rumio S Ménard A Balsari 2006 Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer J Immunol 176 6624 6630 (Pubitemid 43787845)
3. OL Fahy SL Townley NJ Coates I Clark-Lewis SR McColl 2004 Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3α/CCL20 Lab Invest 84 1501 1511 10.1038/labinvest.3700176 1:CAS:528:DC%2BD2cXhtVWrsLnE (Pubitemid 39482167)
4. NS Forbes LL Munn D Fukumura RK Jain 2003 Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors Cancer Res 63 5188 5193 1:CAS:528:DC%2BD3sXntlekt7s%3D (Pubitemid 37139825)
5. C Gil-Cruz S Bobat JL Marshall RA Kingsley EA Ross IR Henderson DL Leyton RE Coughlan M Khan KT Jensen CD Buckley G Dougan IC MacLennan C López-Macías AF Cunningham 2009 The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response Proc Natl Acad Sci USA 106 9803 9808 10.1073/pnas.0812431106 1:CAS:528: DC%2BD1MXotFGjs7o%3D
6. I King D Bermudes S Lin M Belcourt J Pike K Troy T Le M Ittensohn J Mao W Lang JD Runyan X Luo Z Li LM Zheng 2002 Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent Hum Gene Ther 13 1225 1233 10.1089/104303402320139005 1:CAS:528:DC%2BD38Xlt1Kktro%3D (Pubitemid 34746702)
7. CH Lee JL Hsieh CL Wu PY Hsu AL Shiau 2011 T cell augments the antitumor activity of tumor-targeting Salmonella Appl Microbiol Biotechnol 90 1381 1388 10.1007/s00253-011-3180-z 1:CAS:528:DC%2BC3MXlt1GltLg%3D
8. CH Lee CL Wu SH Chen AL Shiau 2009 Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica serovar choleraesuis J Immunother 32 376 388 10.1097/CJI.0b013e31819d4ebc 1:CAS:528: DC%2BD1MXkvVGmsbs%3D
9. CH Lee CL Wu AL Shiau 2004 Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models J Gene Med 6 1382 1393 10.1002/jgm.626 1:CAS:528:DC%2BD2MXhsVeiu7k%3D (Pubitemid 40287709)
10. CH Lee CL Wu AL Shiau 2008 Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma Int J Cancer 122 930 935 10.1002/ijc.23047 1:CAS:528:DC%2BD1cXhsFShsb4%3D
11. CH Lee CL Wu AL Shiau 2008 Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis Clin Cancer Res 14 1905 1912 10.1158/1078-0432.CCR-07-2050 1:CAS:528:DC%2BD1cXjtleis7c%3D (Pubitemid 351469478)
12. KB Low M Ittensohn T Le J Platt S Sodi M Amoss O Ash E Carmichael A Chakraborty J Fischer SL Lin X Luo SI Miller L Zheng I King JM Pawelek D Bermudes 1999 Lipid A mutant Salmonella with suppressed virulence and TNF-α induction retain tumor-targeting in vivo Nat Biotechnol 17 37 41 1:CAS:528:DyaK1MXks1OisQ%3D%3D (Pubitemid 29037207)
13. P Mastroeni C Simmons R Fowler CE Hormaeche G Dougan 2000 Igh-6-/- (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar Typhimurium and show impaired Th1 T-cell responses to Salmonella antigens Infect Immun 68 46 53 10.1128/IAI.68.1.46-53.2000 1:CAS:528:DC%2BD3cXhs1Ojsg%3D%3D (Pubitemid 30016676)
14. SJ McSorley MK Jenkins 2000 Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium Infect Immun 68 3344 3348 10.1128/IAI.68.6.3344-3348.2000 1:CAS:528:DC%2BD3cXjsF2jsrw%3D (Pubitemid 30340429)
15. S Mei J Theys W Landuyt J Anne P Lambin 2002 Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium Anticancer Res 22 3261 3266 1:CAS:528:DC%2BD3sXoslynsg%3D%3D (Pubitemid 36070101)
16. HW Mittrücker SH Kaufmann 2000 Immune response to infection with Salmonella typhimurium in mice J Leukoc Biol 67 457 463
17. HW Mittrücker B Raupach A Köhler SH Kaufmann 2000 Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection J Immunol 164 1648 1652 (Pubitemid 30108710)
18. AF Ochsenbein T Fehr C Lutz M Suter F Brombacher H Hengartner RM Zinkernagel 1999 Control of early viral and bacterial distribution and disease by natural antibodies Science 286 2156 2159 10.1126/science.286.5447.2156 1:CAS:528:DyaK1MXotFGrtL4%3D (Pubitemid 129516290)
19. JM Pawelek KB Low D Bermudes 2003 Bacteria as tumour-targeting vectors Lancet Oncol 4 548 556 10.1016/S1470-2045(03)01194-X (Pubitemid 38351712)
20. JM Pawelek KB Low D Bermudes 1997 Tumor-targeted Salmonella as a novel anticancer vector Cancer Res 57 4537 4544 1:CAS:528:DyaK2sXmslKqt7Y%3D (Pubitemid 27441058)
21. RR Reid AP Prodeus W Khan T Hsu FS Rosen MC Carroll 1997 Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide J Immunol 159 970 975 1:CAS:528:DyaK2sXksVyqt7o%3D (Pubitemid 127484252)
22. AL Shiau CC Chen YT Yo CY Chu SY Wang CL Wu 2005 Enhancement of humoral and cellular immune responses by an oral Salmonella choleraesuis vaccine expressing porcine prothymosin α Vaccine 239 5563 5571 10.1016/j.vaccine.2005.07.004 (Pubitemid 41608606)
23. HW Smith 1965 The immunization of mice, calves and pigs against Salmonella dublin and Salmonella cholera-esuis infections J Hyg (Lond) 63 117 135 10.1017/S0022172400045022 1:STN:280:DyaF2M%2Fns1CktQ%3D%3D
24. K Westphal S Leschner J Jablonska H Loessner S Weiss 2008 Containment of tumor-colonizing bacteria by host neutrophils Cancer Res 68 2952 2960 10.1158/0008-5472.CAN-07-2984 1:CAS:528:DC%2BD1cXks1Ghsr8%3D (Pubitemid 351556296)
25. L Yuhua G Kunyuan C Hui X Yongmei S Chaoyang T Xun R Daming 2001 Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium Int J Cancer 94 438 443 10.1002/ijc.1489 1:STN:280: DC%2BD3MnpsFKjsQ%3D%3D (Pubitemid 32906078)